Chapter/Section Purchase

1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 XIFAXAN
1.2.3 Viberzi
1.2.4 Lotronex
1.2.5 Other
1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel
1.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Comparison by Sales Channel: (2021-2027)
1.3.2 Hospitals Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Estimates and Forecasts
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2016-2027
1.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2027
1.4.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Manufacturers
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends
2.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Market Share by Revenue
2.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario by Region
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Country
3.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
3.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Country
3.4.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
3.4.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
3.5.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Country
3.6.1 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
3.6.2 Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
3.7.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Analysis by Type
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2016-2021)

5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Historic Market Analysis by Sales Channel
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2016-2021)
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Sales Channel (2016-2021)

6 Key Companies Profiled
6.1 Bausch Health
6.1.1 Bausch Health Corporation Information
6.1.2 Bausch Health Description and Business Overview
6.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolio
6.1.5 Bausch Health Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Sebela Pharmaceuticals
6.3.1 Sebela Pharmaceuticals Corporation Information
6.3.2 Sebela Pharmaceuticals Description and Business Overview
6.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolio
6.3.5 Sebela Pharmaceuticals Recent Developments/Updates
6.4 Astellas Pharmaceuticals
6.4.1 Astellas Pharmaceuticals Corporation Information
6.4.2 Astellas Pharmaceuticals Description and Business Overview
6.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolio
6.4.5 Astellas Pharmaceuticals Recent Developments/Updates
6.5 Amneal Pharms
6.5.1 Amneal Pharms Corporation Information
6.5.2 Amneal Pharms Description and Business Overview
6.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolio
6.5.5 Amneal Pharms Recent Developments/Updates
6.6 Pharscin Pharma
6.6.1 Pharscin Pharma Corporation Information
6.6.2 Pharscin Pharma Description and Business Overview
6.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Portfolio
6.6.5 Pharscin Pharma Recent Developments/Updates

7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis
7.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
7.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
8.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers

9 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Dynamics
9.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Trends
9.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Drivers
9.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
9.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints

10 Global Market Forecast
10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2022-2027)
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Projections by Sales Channel
10.2.1 Global Forecasted Sales of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Sales Channel (2022-2027)
10.2.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Sales Channel (2022-2027)
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer